CCAP
Crescent Capital BDC, Inc.
NasdaqGMUSDEQUITY
Financial Services
DELAYED
Last price
10.74
▲ 0.06 (0.56%)
MARKET · —
Price
Open
10.68
Prev close
10.68
Day high
10.75
Day low
10.59
Volume
224.13K
Market cap
$394.62M
P/E (TTM)
—
52W range
10.59 – 16.04
Trailing performance
Returnvs SPY
1W
-3.95%
-2.6%
1M
-0.65%
-4.4%
3M
-6.38%
-9.5%
6M
-19.53%
-30.6%
YTD
-23.77%
-36.1%
1Y
-29.40%
-49.4%
3Y
-35.48%
-109.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$394.62M
Enterprise value$1.31B
Revenue (TTM)$156.40M
Gross profit$156.40M
EBITDA—
Net income$-3.17M
EPS (TTM)$-0.09
Free cash flow$49.66M
Total cash$15.60M
Total debt$925.99M
Book value / share$17.82
Shares outstanding36.85M
Float—
Short % of float3.38%
Dividend yield14.20%
Beta (5Y)0.58
Valuation & profitability ratios
Trailing P/E—
Forward P/E7.56
PEG ratio0.89
Price / sales—
Price / book0.60
EV / revenue8.34
EV / EBITDA—
Gross margin100.00%
Operating margin78.37%
Profit margin-2.03%
Return on equity-0.46%
Return on assets4.59%
Debt / equity141.06
Current ratio1.22
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $167.28M | $197.36M | $184.13M | $116.72M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $34.51M | $73.65M | $83.84M | $15.54M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | $34.51M | $73.65M | $83.84M | $15.54M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.37 | 0.36 | -1.8% |
| Dec 2025 | 0.43 | 0.45 | +4.7% |
| Sep 2025 | 0.46 | 0.19 | -58.7% |
| Jun 2025 | 0.47 | 0.46 | -1.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.37 | 6 | $37.12M | -13.7% |
| Next quarter | 0.36 | 6 | $36.36M | -10.9% |
| Current year | 1.48 | 6 | $146.97M | -12.1% |
| Next year | 1.42 | 7 | $142.69M | -2.9% |
Analyst targets & ownership
Mean target$12.64
High target$14.00
Low target$11.00
Implied upside17.72%
Analyst count7
ConsensusBUY
Strong buy / Buy1 / 2
Hold4
Sell / Strong sell0 / 0
Held by insiders3.40%
Held by institutions71.41%
Institutions holding107
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.25M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 21, 26 | CHUNG HENRY President |
BUY | 4.50K | $51.52K | Direct |
| May 20, 26 | BREAUX JASON A. Chief Executive Officer |
BUY | 5.00K | $55.95K | Direct |
| May 19, 26 | STRANDBERG STEVEN F. Director |
BUY | 85.00K | $958.49K | Indirect |
| May 18, 26 | LOMBARD GERHARD Chief Financial Officer |
BUY | 1.00K | $11.12K | Direct |
| Nov 17, 25 | LOMBARD GERHARD Chief Financial Officer |
BUY | 2.00K | $26.68K | Direct |
| Aug 28, 25 | BOUEK KIRILL Officer |
BUY | 200 | $3.13K | Direct |
| Aug 25, 25 | BARRIOS RAYMOND F. Officer |
BUY | 3.25K | $50.71K | Direct |
| Jun 4, 25 | UFCW-NORTHERN CALIFORNIA EMPLOYERS JOINT PENSION PLAN Beneficial Owner of more than 10% of a Class of Security |
SELL | 572.89K | $8.68M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARRIOS RAYMOND F. |
Officer | 19.18K | Purchase |
BOUEK KIRILL |
Officer | 1.06K | Purchase |
BREAUX JASON A. |
Chief Executive Officer | 52.64K | Purchase |
CHUNG HENRY |
President | 20.72K | Purchase |
LOMBARD GERHARD |
Chief Financial Officer | 37.37K | Purchase |
STRANDBERG STEVEN F. |
Director | — | Purchase |
UFCW-NORTHERN CALIFORNIA EMPLOYERS JOINT PENSION PLAN |
Beneficial Owner of more than 10% of a Class of Security | 3.66M | Sale |
Moving averages & technicals
SMA 10
11.05
-2.82% from price
SMA 20
11.15
-3.97% from price
SMA 50
11.11
-3.63% from price
SMA 100
11.79
-8.93% from price
SMA 200
12.87
-16.78% from price
EMA 12
10.99
-2.31% from price
EMA 26
11.09
-3.20% from price
EMA 50
11.26
-4.60% from price
RSI (14)
40.8
Neutral
MACD (12,26,9)
-0.10
Hist -0.08
ATR (14)
0.33
3.05% of price
Realised vol 30D
29.0%
Annualised
Bollinger upper
11.84
20, 2σ
Bollinger lower
10.47
20, 2σ
50 / 200 cross
Death
11.11 vs 12.87
Trend bias
Below 200
-16.78%
Risk profile
Beta vs SPY
0.65
Less volatile than market
Correlation to SPY
0.31
Loosely linked
Realised vol 30D
29.0%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-33.0%
Peak to trough
Max drawdown 5Y
-48.9%
Peak to trough
ATR 14
0.33
3.05% of price
Beta (reported)
0.58
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.42
Call-heavy session
Put / call open interest
0.59
Positioning, not flow
Max pain
12.50
+16.7% from spot
ATM implied vol
252.5%
Nearest strike to spot
Skew (10% OTM)
-19.9%
Calls bid over puts
Call volume
88
Contracts, this expiry
Put volume
37
Contracts, this expiry
Heaviest call OI
15.00
181 contracts
Heaviest put OI
10.00
128 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform From Outperform, Adjusts Price Target to $12 From $13
MT Newswires · 5d ago
Oppenheimer Adjusts PT on Crescent Capital BDC to $14 From $16, Maintains Perform Rating
MT Newswires · 9d ago
B. Riley Adjusts Crescent Capital BDC Price Target to $12.50 From $13.50, Maintains Neutral Rating
MT Newswires · 10d ago
Crescent Capital BDC Inc (CCAP) (Q2 2026) Earnings Call Highlights: NAV Declines for Eighth ...
GuruFocus.com · 11d ago
Crescent Capital BDC Q2 Earnings Call Highlights
MarketBeat · 11d ago
Crescent Capital BDC, Inc. Q2 2026 Earnings Call Summary
Moby · 11d ago
Crescent Capital BDC (CCAP) Misses Q2 Earnings and Revenue Estimates
Zacks · 12d ago
Crescent Capital BDC: Q2 Earnings Snapshot
Associated Press · 12d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.